Aprotinin in open-heart surgery: background and results in patients having aortocoronary bypass grafts
暂无分享,去创建一个
[1] W. van Oeveren,et al. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.
[2] D. Royston,et al. The serine antiprotease aprotinin (Trasylol): a novel approach to reducing postoperative bleeding. , 1990, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[3] I. Goel,et al. Prophylactic tranexamic acid decreases bleeding after cardiac operations. , 1990, The Journal of thoracic and cardiovascular surgery.
[4] W. Bechstein,et al. EFFECT OF APROTININ ON INTRAOPERATIVE BLEEDING AND FIBRINOLYSIS IN LIVER TRANSPLANTATION , 1989, The Lancet.
[5] D. Royston,et al. Reduced blood loss following open heart surgery with aprotinin (Trasylol) is associated with an increase in intraoperative activated clotting time (ACT). , 1989, Journal of cardiothoracic anesthesia.
[6] M. Jochum,et al. REDUCTION OF HOMOLOGOUS BLOOD REQUIREMENT IN CARDIAC SURGERY USING HIGH DOSE APROTININ , 1989 .
[7] G. Lemole,et al. Prophylactic treatment of postperfusion bleeding using EACA. , 1989, Chest.
[8] G. Fraedrich,et al. Reduction of Blood Transfusion Requirement in Open Heart Surgery by Administration of High Doses of Aprotinin - Preliminary Results , 1989, The Thoracic and cardiovascular surgeon.
[9] F. Sebening,et al. Reduction of Homologous Blood Requirement in Cardiac Surgery by Intraoperative Aprotinin Application - Clinical Experience in 152 Cardiac Surgical Patients , 1989, The Thoracic and cardiovascular surgeon.
[10] D. Cosgrove,et al. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). , 1989, The Journal of thoracic and cardiovascular surgery.
[11] R. Weisel,et al. Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass. , 1988, The Journal of thoracic and cardiovascular surgery.
[12] O. N. Okike,et al. The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind randomized study. , 1988, The Journal of thoracic and cardiovascular surgery.
[13] K. M. Taylor,et al. EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERY , 1987, The Lancet.
[14] W. van Oeveren,et al. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. , 1987, The Annals of thoracic surgery.
[15] K. Nolop,et al. Increased pulmonary transvascular protein flux after canine cardiopulmonary bypass. Association with lung neutrophil sequestration and tissue peroxidation. , 1986, The American review of respiratory disease.
[16] R. Weintraub,et al. Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac Surgery , 1986 .
[17] J. Fleming,et al. Increased production of peroxidation products associated with cardiac operations. Evidence for free radical generation. , 1986, The Journal of thoracic and cardiovascular surgery.
[18] R. S. Mitchell,et al. A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations. , 1986, The Journal of thoracic and cardiovascular surgery.
[19] D. Killen,et al. Coronary artery bypass following percutaneous transluminal coronary angioplasty. , 1985, The Annals of thoracic surgery.
[20] H. Fritz,et al. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. , 1983, Arzneimittel-Forschung.
[21] J. Northrop,et al. ISOLATION FROM BEEF PANCREAS OF CRYSTALLINE TRYPSINOGEN, TRYPSIN, A TRYPSIN INHIBITOR, AND AN INHIBITOR-TRYPSIN COMPOUND , 1936, The Journal of general physiology.
[22] H. Kraut,et al. Über die Inaktivierung des Kallikreins. (VI. Mitteilung über dieses Kreislaufhormon.) , 1930 .